Trials / Completed
CompletedNCT02576847
Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety of Omiganan Topical Gel in Subjects With Rosacea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 307 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the long-term safety of once-daily application of Omiganan topical gel in subjects with severe papulopustular rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omiganan | Topical gel |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-07-14
- Completion
- 2018-02-08
- First posted
- 2015-10-15
- Last updated
- 2022-07-19
- Results posted
- 2022-07-06
Locations
28 sites across 8 countries: United States, Australia, Canada, France, Netherlands, New Zealand, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02576847. Inclusion in this directory is not an endorsement.